/Investor DB

Amgen Ventures — 2020 Investments

2 investments dated 2020 · listed companies and verified rows first · show all

GPB Scientific, Inc.gpbscientific.comApr 2020

BiotechRichmond, US

Michael D. Grisham(Chief Executive Officer)in

Co-investorsVensana Capital

Imagoimagobio.comin𝕏Nov 2020 · $80Macquired by Merck

A pharmaceutical company that develops medicines and vaccines, with research pipelines and clinical trials aimed at new treatments.

BiotechHealthtech

Co-investorsFrazier Life SciencesHighlight CapitalMRL Ventures FundXeraya CapitalBlackRockBlackstone Life Sciences+5 more

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.